GENE ONLINE|News &
Opinion
Blog

Antibody
Trials & Approvals
Lilly’s Donanemab Aces Phase 2 Trial, Slows Clinical Decline in Alzheimer’s Patients
2021-01-15
Cancer
Novartis Fortifies Immuno-Oncology Franchise with BeiGene Collaboration
2021-01-15
R&D Antibody
Compugen, AstraZeneca’s Ongoing Collaboration Achieves Preclinical Milestone
2021-01-06
Trials & Approvals HER2
Roche Bags EU Nod for a Novel Delivery Method in Breast Cancer Treatment
2020-12-25
R&D Influenza
Vir Biotechnology Showcases Data on a Potential Therapy for Influenza
2020-10-24
COVID-19 Monoclonal Antibody
Lilly’s Coronavirus Antibody Treatment Hits Pause Button Over Potential Safety Issues
2020-10-16
COVID-19 Clinical Trial
GSK, Vir Collaboration Drives Advanced Clinical Trial for Novel COVID-19 Antibody Forward
2020-10-11
Biotech Duo Revise Co-development & Commercialization Agreement of Intelligent Drug Delivery System
2020-10-08
COVID-19 Antibody
COVID-19: Early Data Shows Regeneron’s Antibody Cocktail Curbs Virus, Speeds Recovery
2020-10-01
Trials & Approvals Rare Disease
Potential Treatment for Osteogenesis Imperfecta Receives FDA’s “Rare Pediatric Disease Designation”
2020-09-27
Trials & Approvals PD-L1
BMS Enters Esophageal Cancer Therapy Area Amidst High Competition
2020-09-27
Trials & Approvals Huntington's Disease
Vaccinex’s Drug Flounders Huntington’s Trial, but Shows Promise against Another Neurodegenerative Disease
2020-09-24
R&D Alzheimer's Disease
UCB Joins Forces with Roche to Develop Antibody Treatment for Alzheimer’s
2020-07-31
COVID-19
COVID-19: AstraZeneca and University of Oxford’s Vaccine Candidate Shows Promise in Early Human Trials
2020-07-20
COVID-19
Regeneron Secures $4.5 Billion Worth of Contracts from the US for Combating COVID-19
2020-07-10
1 2 3 4 5 6
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top